Concepedia

Publication | Closed Access

Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis

DOI

50

Citations

25

References

2021

Year

Makoto Chuma, Haruki Uojima, Nobuhiro Hattori, Yoshitaka Arase, Taito Fukushima, Shunji Hirose, Satoshi Kobayashi, Makoto Ueno, Shun Tezuka, Shuichiro Iwasaki,
Hepatology Research

Abstract

In real-world practice, ATZ + BV treatment might offer significant benefits in patients who meet B-IMbrave150 criteria or have low NLR.

References

YearCitations

Page 1